ProgressImage ProgressImage
Alkem Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 539523 border-img ISIN Demat INE540L01014 border-img Book Value 1,170.81 border-img NSE Symbol ALKEM border-img Div & Yield % 1 border-img Market Cap ( Cr.) 63369.45 border-img P/E 28.27 border-img EPS 187.45 border-img Face Value 2
Mar 2026
( Cr.)
Mar 2025
( Cr.)
Mar 2024
( Cr.)
Mar 2023
( Cr.)
Mar 2022
( Cr.)
Mar 2021
( Cr.)
SOURCES OF FUNDS :       
Share Capital 23.9123.9123.9123.9123.9123.91
Reserves Total 13974.8512297.9210530.709325.948719.757601.84
Equity Share Warrants 0.000.000.000.000.000.00
Equity Application Money 0.000.000.000.000.000.00
Total Shareholders Funds 13998.7612321.8310554.619349.858743.667625.75
Secured Loans 218.3662.88172.02119.311010.07327.88
Unsecured Loans 393.08375.83833.191062.381283.711055.63
Total Debt 611.44438.711005.211181.692293.781383.51
Other Liabilities 460.61686.88339.19291.48263.91197.35
Total Liabilities 15070.8113447.4211899.0110823.0211301.359206.61
APPLICATION OF FUNDS :       
Gross Block 3216.813083.403144.312932.252826.982481.89
Less : Accumulated Depreciation 1667.301492.061362.071107.16944.91723.53
Less:Impairment of Assets 0.000.000.000.000.000.00
Net Block 1549.511591.341782.241825.091882.071758.36
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress 122.7876.5090.78228.75232.45323.26
Producing Properties 0.000.000.000.000.000.00
Investments 5551.934406.782828.983005.552528.612152.38
Current Assets, Loans & Advances       
Inventories 1631.761522.901849.561724.661975.731513.26
Sundry Debtors 1567.241559.841753.641768.341768.221556.55
Cash and Bank Balance 1289.471056.111065.852163.872297.211673.36
Loans and Advances 2800.502559.913227.27802.75684.29726.20
Total Current Assets 7288.976698.767896.326459.626725.455469.37
Less : Current Liabilities and Provisions       
Current Liabilities 1981.961974.112028.151683.761673.801367.46
Provisions 208.36174.07110.64224.44194.02198.66
Total Current Liabilities & Provisions 2190.322148.182138.791908.201867.821566.12
Net Current Assets 5098.654550.585757.534551.424857.633903.25
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets 1677.811660.351540.211292.741248.661143.51
Deferred Tax Liability 155.72231.21253.55207.82199.92189.08
Net Deferred Tax 1522.091429.141286.661084.921048.74954.43
Other Assets 1225.851393.08152.82127.29751.85114.93
Total Assets 15070.8113447.4211899.0110823.0211301.359206.61
Contingent Liabilities 1126.44877.0090.58289.52274.92287.75
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement   |    CDSL MyEasi   |    TRAI Notice on UCC   |    SEBI Risk Disclosure   |    Investor Notice

Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

x
x
×
Let's Chat
imsl-img
close
refresh